A complete application in a minute
Tailored resume and cover letter, ready to send.
CSL Behring is seeking a scientifically skilled professional to contribute to clinical development programs in hematology. You will provide input for study execution, author key documents, and help translate strategy into actionable deliverables across cross-functional teams.
The role involves medical oversight, data interpretation, and collaboration with CROs to ensure safety and data integrity, with potential leadership of development programs. Hybrid onsite requirement applies.
*** This is a hybrid position with a minimum of 3 days onsite required on a weekly basis. Relocation and mobility assistance are not provided.
The expected base salary range for this position at hiring is $168,000 - $199,000/yr. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the Waltham, MA USA work location at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.
#LI-HYBRID
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .